Dataset Information


Comparative transcriptome analysis of two S. aureus strains with different susceptibilities to mersacidin.

ABSTRACT: The lantibiotic mersacidin is an antimicrobial peptide of 20 amino acids that is produced by Bacillus sp. strain HIL Y-85,54728. Lantibiotics are antibiotics containing nonproteinogenic amino acids like lanthionine and/or 3-methyllanthionine. Mersacidin interferes with cell wall biosynthesis by targeting the peptidoglycan precursor lipid II and inhibits the growth of MRSA and other gram-positive bacteria. Therefore, mersacidin could be a lead substance for the development of new antibacterial agents. The clinical VISA isolates S. aureus 137/93A and its spontaneous mutant S. aureus 137/93G show reduced sensitivity towards mersacidin. This phenotype could not be traced to factors being responsible for vancomycinresistance (i.e. the thickened cell wall). Here, we focussed on the comparative transcriptome analysis of S. aureus 137/93A and S. aureus SG511 (sensitive strain) via full genome S. aureus microarrays to identify genes involved in the reduced sensitivity towards mersacidin.

ORGANISM(S): Staphylococcus aureus Staphylococcus aureus subsp. aureus N315

PROVIDER: GSE12016 | GEO | 2009/01/17



Similar Datasets

2008-10-23 | GSE9261 | GEO
| E-GEOD-43759 | biostudies-arrayexpress
2013-03-12 | GSE10529 | GEO
2013-05-20 | GSE43759 | GEO
2009-08-17 | GSE17391 | GEO
2017-06-02 | GSE99563 | GEO
2019-11-11 | GSE122362 | GEO
2015-10-01 | GSE62091 | GEO
| E-GEOD-14669 | biostudies-arrayexpress
2014-06-06 | GSE57908 | GEO